皮膚科治療薬の市場規模、シェア、動向分析レポート：治療法別、タイプ別、投与経路別、薬剤クラス別、流通チャネル別、地域別、セグメント別予測、2025年～2030年

皮膚科治療薬市場の成長と動向

Grand View Research, Inc.の最新レポートによると、皮膚科治療薬の世界市場規模は2030年までに423億米ドルに達し、2025～2030年のCAGRは10.1%で拡大すると予測されています。

世界の皮膚科治療薬市場は、皮膚疾患の発見と治療のための医療資源の利用可能性、不健康な食習慣による栄養不足、生活習慣病に関する意識の高まり、汚染レベルの上昇、人口の免疫力不足などの促進要因によって成長すると予想されます。さらに、一人当たり所得の上昇と購買力の向上が、この市場の推進力となっています。

にきびセグメントは、2022～2028年にかけてCAGR 10.5％で拡大すると予想されます。ニキビは、古い皮膚や皮膚腺の油脂腺が詰まり、シミや吹き出物、時には嚢胞を形成する皮膚疾患です。さらに、感染した毛包が皮膚の毛穴から始まるニキビを引き起こします。にきびは、顔、肩、胸、背中などに、にきび、黒ずみ、白斑の形でぶつぶつを作る。にきびは皮膚科医による効果的な治療で治すことができ、肌の見た目も改善されるため、皮膚科治療薬市場に貢献しています。

北米は2021年に35%以上の最大の売上シェアを占めました。米国はこの地域市場の成長にプラスに寄与しています。定評のある製薬ベンダーの存在は、市場成長を支える重要な要因のひとつです。この地域は、医療のインフラや、がんを治療するための最適な薬剤の革新と生産に役立つ先進的研究開発活動という点で、新技術を打ち出す有望な地域のひとつです。同地域では、医療産業において、診断と提供ベースの医療サービスを提供するために、従来の治療から消費者主導型へと急速にシフトしていることが確認されています。さらに、医療産業における薬剤の入手のしやすさや患者への償還施策も、同地域の市場牽引に寄与しています。

皮膚科治療薬市場レポートハイライト

• 乾癬セグメントは2024年に50.6%の最大売上シェアを占め、市場を独占しました。これは疾患に対する認識と効果的な治療に対する需要に起因しています。
• 処方薬セグメントは2024年に61.9%の最大収益シェアで市場を独占し、予測期間のCAGRは10.4%で最速の成長が見込まれます。
• 局所投与が2024年に60.0％の最大売上シェアで市場を独占しました。
• 副腎皮質ステロイドは、2024年に30.1％の最大売上シェアで市場を独占しました。これは、皮膚感染症患者の増加と研究開発の成長に起因しています。
• 小売薬局が市場を独占し、2024年の売上シェアは50.6%で最大となりました。これは、OTC皮膚科学製品の成長と皮膚疾患に対する認識によるものです。
• 北米の皮膚科治療薬市場は、2024年に38.6%の最大売上シェアを占め、市場を独占しました。
• 北米の皮膚科治療薬市場は、2024年に33.6%の最大売上シェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 皮膚科治療薬市場の変数、動向、範囲

• 市場イントロダクション/系統展望
• 市場規模と成長展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 皮膚科治療薬市場分析ツール
  • ポーターの分析
  • PESTEL分析

第4章 皮膚科治療薬市場：治療法別、推定・動向分析

• 治療法市場シェア、2024年と2030年
• 治療法セグメントダッシュボード
• 市場規模と予測と動向分析、治療法別、2018～2030年
• ニキビ
• 乾癬
• 酒さ様皮膚炎
• 脱毛症
• その他

第5章 皮膚科治療薬市場：タイプ別、推定・動向分析

• タイプ市場シェア、2024年と2030年
• タイプセグメントダッシュボード
• 市場規模と予測と動向分析、タイプ別、2018～2030年
• 処方箋
• 市販薬（OTC）

第6章 皮膚科治療薬市場：投与経路別、推定・動向分析

• 投与経路市場シェア、2024年と2030年
• 投与経路セグメントダッシュボード
• 市場規模と予測と動向分析、投与経路別、2018～2030年
• 局所投与
• 経口投与
• 非経口投与

第7章 皮膚科治療薬市場： 薬剤クラス、推定・動向分析

• 薬剤クラス市場シェア、2024年と2030年
• 薬剤クラスセグメントダッシュボード
• 市場規模と予測と動向分析、薬剤クラス別、2018～2030年
• コルチコステロイド
• レチノイド
• 抗生物質
• 抗真菌薬
• カルシニューリン阻害剤
• その他

第8章 皮膚科治療薬市場：流通チャネル別、推定・動向分析

• 流通チャネル市場シェア、2024年と2030年
• 流通チャネルセグメントダッシュボード
• 市場規模と予測と動向分析、流通チャネル別、2018～2030年
• 病院薬局
• 小売薬局
• その他

第9章 皮膚科治療薬市場：地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 市場規模と予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 参加者概要
• 企業の市況分析
• 企業分類
• 戦略マッピング
• 企業プロファイル/上場企業
  • AbbVie Inc.
  • Pfizer Inc.
  • GSK plc.
  • Sun Pharmaceutical Industries Ltd.
  • GALDERMA
  • Amgen Inc.
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Eli Lilly and Company
  • Almirall, SA
  • Bausch Health Companies Inc.

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. Global Dermatological Drugs Market, by Region, 2018 - 2030 (USD Million)
• Table 4. Global Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 5. Global Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 6. Global Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 7. Global Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 8. Global Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 9. North America Dermatological Drugs Market, by Country, 2018 - 2030 (USD Million)
• Table 10. North America Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 11. North America Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 12. North America Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 13. North America Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 14. North America Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 15. U.S. Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 16. U.S. Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 17. U.S. Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 18. U.S. Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 19. U.S. Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 20. Canada Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 21. Canada Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 22. Canada Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 23. Canada Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 24. Canada Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 25. Mexico Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 26. Mexico Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 27. Mexico Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 28. Mexico Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 29. Mexico Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 30. Europe Dermatological Drugs Market, by Country, 2018 - 2030 (USD Million)
• Table 31. Europe Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 32. Europe Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 33. Europe Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 34. Europe Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 35. Europe Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 36. UK Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 37. UK Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 38. UK Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 39. UK Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 40. UK Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 41. Germany Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 42. Germany Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 43. Germany Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 44. Germany Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 45. Germany Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 46. France Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 47. France Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 48. France Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 49. France Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 50. France Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 51. Italy Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 52. Italy Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 53. Italy Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 54. Italy Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 55. Italy Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 56. Spain Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 57. Spain Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 58. Spain Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 59. Spain Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 60. Spain Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 61. Denmark Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 62. Denmark Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 63. Denmark Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 64. Denmark Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 65. Denmark Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 66. Sweden Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 67. Sweden Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 68. Sweden Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 69. Sweden Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 70. Sweden Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 71. Norway Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 72. Norway Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 73. Norway Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 74. Norway Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 75. Norway Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 76. Asia Pacific Dermatological Drugs Market, by Country, 2018 - 2030 (USD Million)
• Table 77. Asia Pacific Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 78. Asia Pacific Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 79. Asia Pacific Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 80. Asia Pacific Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 81. Asia Pacific Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 82. Japan Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 83. Japan Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 84. Japan Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 85. Japan Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 86. Japan Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 87. China Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 88. China Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 89. China Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 90. China Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 91. China Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 92. India Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 93. India Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 94. India Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 95. India Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 96. India Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 97. Australia Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 98. Australia Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 99. Australia Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 100. Australia Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 101. Australia Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 102. South Korea Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 103. South Korea l Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 104. South Korea Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 105. South Korea Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 106. South Korea Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 107. Thailand Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 108. Thailand Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 109. Thailand Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 110. Thailand Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 111. Thailand Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 112. Latin America Dermatological Drugs Market, by Country, 2018 - 2030 (USD Million)
• Table 113. Latin America Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 114. Latin America Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 115. Latin America Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 116. Latin America Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 117. Latin America Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 118. Brazil Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 119. Brazil Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 120. Brazil Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 121. Brazil Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 122. Brazil Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 123. Argentina Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 124. Argentina Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 125. Argentina Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 126. Argentina Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 127. Argentina Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 128. Middle East & Africa Dermatological Drugs Market, by Country, 2018 - 2030 (USD Million)
• Table 129. Middle East & Africa Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 130. Middle East & Africa Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 131. Middle East & Africa Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 132. Middle East & Africa Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 133. Middle East & Africa Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 134. South Africa Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 135. South Africa Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 136. South Africa Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 137. South Africa Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 138. South Africa Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 139. Saudi Arabia Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 140. Saudi Arabia Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 141. Saudi Arabia Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 142. Saudi Arabia Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 143. Saudi Arabia Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 144. UAE Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 145. UAE Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 146. UAE Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 147. UAE Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 148. UAE Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
• Table 149. Kuwait Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
• Table 150. Kuwait Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
• Table 151. Kuwait Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 152. Kuwait Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
• Table 153. Kuwait Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Dermatological Drugs Market Segmentation
• Fig. 2 Market Research Process
• Fig. 3 Data Triangulation Techniques
• Fig. 4 Primary Research Pattern
• Fig. 5 Market Research Approaches
• Fig. 6 Value Chain-Based Sizing & Forecasting
• Fig. 7 Market Formulation & Validation
• Fig. 8 Market Snapshot

Fig. 9 Segment Outlook (USD Million)

• Fig. 10 Competitive Landscape
• Fig. 11 Dermatological Drugs Market Dynamics
• Fig. 12 Dermatological Drugs Market: Porter's Five Forces Analysis
• Fig. 13 Dermatological Drugs Market: Pestle Analysis
• Fig. 14 Dermatological Drugs Market: Therapy Segment Dashboard
• Fig. 15 Dermatological Drugs Market: Therapy Market Share Analysis, 2024 & 2030
• Fig. 16 Acne Market (USD Million)
• Fig. 17 Psoriasis Market (USD Million)
• Fig. 18 Rosacea Market (USD Million)
• Fig. 19 Alopecia Market (USD Million)
• Fig. 20 Others Market, 2018 - 2030 (USD Million)
• Fig. 21 Dermatological Drugs Market: Type Segment Dashboard
• Fig. 22 Dermatological Drugs Market: Type Market Share Analysis, 2024 & 2030
• Fig. 23 Prescription Market (USD Million)
• Fig. 24 Over-the-counter (OTC) Market (USD Million)
• Fig. 25 Dermatological Drugs Market: Route of Administration Segment Dashboard
• Fig. 26 Dermatological Drugs Market: Route of Administration Market Share Analysis, 2024 & 2030
• Fig. 27 Topical Administration Market (USD Million)
• Fig. 28 Oral Administration Market (USD Million)
• Fig. 29 Parenteral Administration Market (USD Million)
• Fig. 30 Dermatological Drugs Market: Drug Class Segment Dashboard
• Fig. 31 Dermatological Drugs Market: Drug Class Market Share Analysis, 2024 & 2030
• Fig. 32 Corticosteroids Market (USD Million)
• Fig. 33 Retinoids Market (USD Million)
• Fig. 34 Antibiotics Market (USD Million)
• Fig. 35 Antifungals Market (USD Million)
• Fig. 36 Calcineurin Inhibitors Market (USD Million)
• Fig. 37 Others Market, 2018 - 2030 (USD Million)
• Fig. 38 Dermatological Drugs Market: Distribution Channel Segment Dashboard
• Fig. 39 Dermatological Drugs Market: Distribution Channel Market Share Analysis, 2024 & 2030
• Fig. 40 Hospital Pharmacies Market, 2018 - 2030 (USD Million)
• Fig. 41 Retail Pharmacies Market, 2018 - 2030 (USD Million)
• Fig. 42 Others Market, 2018 - 2030 (USD Million)
• Fig. 43 Distance Correspondence Market, 2018 - 2030 (USD Million)
• Fig. 44 Regional Marketplace: Key Takeaways
• Fig. 45 North America Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 46 U.S. Country Dynamics
• Fig. 47 U.S. Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 48 Canada Country Dynamics
• Fig. 49 Canada Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 50 Mexico Country Dynamics
• Fig. 51 Mexico Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 52 Europe Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 53 UK Country Dynamics
• Fig. 54 UK Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 55 Germany Country Dynamics
• Fig. 56 Germany Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 57 France Country Dynamics
• Fig. 58 France Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 59 Italy Country Dynamics
• Fig. 60 Italy Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 61 Spain Country Dynamics
• Fig. 62 Spain Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 63 Denmark Country Dynamics
• Fig. 64 Denmark Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 65 Sweden Country Dynamics
• Fig. 66 Sweden Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 67 Norway Country Dynamics
• Fig. 68 Norway Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 69 Asia Pacific Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 70 Japan Country Dynamics
• Fig. 71 Japan Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 72 China Country Dynamics
• Fig. 73 China Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 74 India Country Dynamics
• Fig. 75 India Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 76 Australia Country Dynamics
• Fig. 77 Australia Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 78 South Korea Country Dynamics
• Fig. 79 South Korea Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 80 Thailand Country Dynamics
• Fig. 81 Thailand Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 82 Latin America Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 83 Brazil Country Dynamics
• Fig. 84 Brazil Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 85 Argentina Country Dynamics
• Fig. 86 Argentina Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 87 MEA Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 88 South Africa Country Dynamics
• Fig. 89 South Africa Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 90 Saudi Arabia Country Dynamics
• Fig. 91 Saudi Arabia Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 92 UAE Country Dynamics
• Fig. 93 UAE Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 94 Kuwait Country Dynamics
• Fig. 95 Kuwait Dermatological Drugs Market, 2018 - 2030 (USD Million)
• Fig. 96 Company Categorization
• Fig. 97 Company Market Position Analysis
• Fig. 98 Strategic Framework

Dermatological Drugs Market Growth & Trends:

The global dermatological drugs market size is expected to reach USD 42.3 billion by 2030, expanding at a CAGR of 10.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The global dermatological drugs market is expected to grow due to driving factors such as the availability of medical resources for detecting and treating skin diseases, nutritional deficiency due to unhealthy food habits, increasing awareness when it comes to lifestyle diseases, and increasing pollution levels, and lack of immunity in the population. Additionally, the rising per capita income and the increasing purchasing power are the driving forces in this market.

The acne segment is expected to expand with a CAGR of 10.5% from 2022 to 2028. Acne is a skin condition where dead skin and oil glands of skin glands are clogged, forming spots, pimples, and sometimes cysts. Additionally, infected hair follicles cause acne, which starts from the skin's pores. Acne causes bumps on the face, shoulders, chest, and back in the form of pimples, blackheads, and whiteheads. Acne can be cured, and the appearance of the skin can be improved with effective treatment from dermatologists, contributing to the dermatological drug market.

North America held the largest revenue share of more than 35% in 2021. The U.S. is positively contributing to the growth of the regional market. The presence of well-established pharmaceutical vendors is one of the key factors supporting the market growth. This region is one of the promising regions to launch new technology in terms of healthcare infrastructure and advanced research and development activities that help innovate and produce the most appropriate drugs to cure cancer. It is observed that in the region, there is a rapid shift in the healthcare industry to consumer-driven from traditional treatment for providing diagnosis and provision-based health services. Additionally, ease of availability of drugs and reimbursement policies for the patient in the healthcare industry contributes to driving the market in the region.

Dermatological Drugs Market Report Highlights:

• The psoriasis segment dominated the market with the largest revenue share of 50.6% in 2024, which can be attributed to the awareness of the disease and the demand for effective treatments.
• The prescription segment dominated the market for the largest revenue share of 61.9% in 2024 and is expected to grow over the fastest CAGR of 10.4% over the forecast period.
• Topical administration dominated the market with the largest revenue share of 60.0% in 2024.
• Corticosteroids dominated the market with the largest revenue share of 30.1% in 2024. This can be attributed to rising skin infection cases and the growth of research and development.
• Retail pharmacies dominated the market, with the largest revenue share of 50.6% in 2024. This can be attributed to OTC dermatological product growth and awareness of skin conditions.
• The dermatological drugs market in North America dominated the market with the largest revenue share of 38.6% in 2024, which can be attributed to advancements in drug development and increasing awareness.
• The North America Dermatological Drugs market had the largest revenue share of 33.6% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Dermatological Drugs Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Dermatological Drugs Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining Power of the Suppliers
    • 3.4.1.2. Bargaining Power of the Buyers
    • 3.4.1.3. Threats of Substitution
    • 3.4.1.4. Threats from New Entrants
    • 3.4.1.5. Competitive Rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political Landscape
    • 3.4.2.2. Economic and Social Landscape
    • 3.4.2.3. Technological Landscape
    • 3.4.2.4. Environmental Landscape
    • 3.4.2.5. Legal Landscape

Chapter 4. Dermatological Drugs Market: Therapy Estimates & Trend Analysis

• 4.1. Therapy Market Share, 2024 & 2030
• 4.2. Therapy Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Therapy, 2018 to 2030 (USD Million)
• 4.4. Acne
  • 4.4.1. Acne Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Psoriasis
  • 4.5.1. Psoriasis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Rosacea
  • 4.6.1. Rosacea Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Alopecia
  • 4.7.1. Alopecia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Dermatological Drugs Market: Type Estimates & Trend Analysis

• 5.1. Type Market Share, 2024 & 2030
• 5.2. Type Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 5.4. Prescription
  • 5.4.1. Prescription Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Over-the-counter (OTC)
  • 5.5.1. Over-the-counter (OTC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Dermatological Drugs Market: Route of Administration Estimates & Trend Analysis

• 6.1. Route of Administration Market Share, 2024 & 2030
• 6.2. Route of Administration Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
• 6.4. Topical Administration
  • 6.4.1. Topical Administration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Oral Administration
  • 6.5.1. Oral Administration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Parenteral Administration
  • 6.6.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Dermatological Drugs Market: Drug Class Estimates & Trend Analysis

• 7.1. Drug Class Market Share, 2024 & 2030
• 7.2. Drug Class Segment Dashboard
• 7.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
• 7.4. Corticosteroids
  • 7.4.1. Corticosteroids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Retinoids
  • 7.5.1. Retinoids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Antibiotics
  • 7.6.1. Antibiotics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Antifungals
  • 7.7.1. Antifungals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Calcineurin Inhibitors
  • 7.8.1. Calcineurin Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.9. Others
  • 7.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Dermatological Drugs Market: Distribution Channel Estimates & Trend Analysis

• 8.1. Distribution Channel Market Share, 2024 & 2030
• 8.2. Distribution Channel Segment Dashboard
• 8.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
• 8.4. Hospital Pharmacies
  • 8.4.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Retail Pharmacies
  • 8.5.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Others
  • 8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Dermatological Drugs Market: Regional Estimates & Trend Analysis

• 9.1. Regional Market Share Analysis, 2024 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 9.4. North America
  • 9.4.1. North America Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.2. U.S.
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Regulatory Framework
    • 9.4.2.3. Competitive Insights
    • 9.4.2.4. U.S. Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.3. Canada
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Regulatory Framework
    • 9.4.3.3. Competitive Insights
    • 9.4.3.4. Canada Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.4. Mexico
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Regulatory Framework
    • 9.4.4.3. Competitive Insights
    • 9.4.4.4. Mexico Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.5. Europe
  • 9.5.1. Europe Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.2. UK
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Regulatory Framework
    • 9.5.2.3. Competitive Insights
    • 9.5.2.4. UK Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3. Germany
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Regulatory Framework
    • 9.5.3.3. Competitive Insights
    • 9.5.3.4. Germany Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.4. France
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Regulatory Framework
    • 9.5.4.3. Competitive Insights
    • 9.5.4.4. France Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.5. Italy
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Regulatory Framework
    • 9.5.5.3. Competitive Insights
    • 9.5.5.4. Italy Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.6. Spain
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Regulatory Framework
    • 9.5.6.3. Competitive Insights
    • 9.5.6.4. Spain Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.7. Denmark
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Regulatory Framework
    • 9.5.7.3. Competitive Insights
    • 9.5.7.4. Denmark Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.8. Sweden
    • 9.5.8.1. Key Country Dynamics
    • 9.5.8.2. Regulatory Framework
    • 9.5.8.3. Competitive Insights
    • 9.5.8.4. Sweden Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.9. Norway
    • 9.5.9.1. Key Country Dynamics
    • 9.5.9.2. Regulatory Framework
    • 9.5.9.3. Competitive Insights
    • 9.5.9.4. Norway Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.6. Asia Pacific
  • 9.6.1. Asia Pacific Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.2. China
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Regulatory Framework
    • 9.6.2.3. Competitive Insights
    • 9.6.2.4. China Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.3. Japan
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Regulatory Framework
    • 9.6.3.3. Competitive Insights
    • 9.6.3.4. Japan Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.4. India
    • 9.6.4.1. Key Country Dynamics
    • 9.6.4.2. Regulatory Framework
    • 9.6.4.3. Competitive Insights
    • 9.6.4.4. India Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.5. Australia
    • 9.6.5.1. Key Country Dynamics
    • 9.6.5.2. Regulatory Framework
    • 9.6.5.3. Competitive Insights
    • 9.6.5.4. Australia Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.6. South Korea
    • 9.6.6.1. Key Country Dynamics
    • 9.6.6.2. Regulatory Framework
    • 9.6.6.3. Competitive Insights
    • 9.6.6.4. South Korea Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.7. Thailand
    • 9.6.7.1. Key Country Dynamics
    • 9.6.7.2. Regulatory Framework
    • 9.6.7.3. Competitive Insights
    • 9.6.7.4. Thailand Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.7. Latin America
  • 9.7.1. Latin America Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7.2. Brazil
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Regulatory Framework
    • 9.7.2.3. Competitive Insights
    • 9.7.2.4. Brazil Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7.3. Argentina
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Regulatory Framework
    • 9.7.3.3. Competitive Insights
    • 9.7.3.4. Argentina Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.8. Middle East and Africa
  • 9.8.1. Middle East and Africa Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.8.2. South Africa
    • 9.8.2.1. Key Country Dynamics
    • 9.8.2.2. Regulatory Framework
    • 9.8.2.3. Competitive Insights
    • 9.8.2.4. South Africa Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.8.3. Saudi Arabia
    • 9.8.3.1. Key Country Dynamics
    • 9.8.3.2. Regulatory Framework
    • 9.8.3.3. Competitive Insights
    • 9.8.3.4. Saudi Arabia Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.8.4. UAE
    • 9.8.4.1. Key Country Dynamics
    • 9.8.4.2. Regulatory Framework
    • 9.8.4.3. Competitive Insights
    • 9.8.4.4. UAE Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.8.5. Kuwait
    • 9.8.5.1. Key Country Dynamics
    • 9.8.5.2. Regulatory Framework
    • 9.8.5.3. Competitive Insights
    • 9.8.5.4. Kuwait Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Participant Overview
• 10.2. Company Market Position Analysis
• 10.3. Company Categorization
• 10.4. Strategy Mapping
• 10.5. Company Profiles/Listing
  • 10.5.1. AbbVie Inc.
    • 10.5.1.1. Participant's Overview
    • 10.5.1.2. Financial Performance
    • 10.5.1.3. Product Benchmarking
    • 10.5.1.4. Recent Developments/ Strategic Initiatives
  • 10.5.2. Pfizer Inc.
    • 10.5.2.1. Participant's Overview
    • 10.5.2.2. Financial Performance
    • 10.5.2.3. Product Benchmarking
    • 10.5.2.4. Recent Developments/ Strategic Initiatives
  • 10.5.3. GSK plc.
    • 10.5.3.1. Participant's Overview
    • 10.5.3.2. Financial Performance
    • 10.5.3.3. Product Benchmarking
    • 10.5.3.4. Recent Developments/ Strategic Initiatives
  • 10.5.4. Sun Pharmaceutical Industries Ltd.
    • 10.5.4.1. Participant's Overview
    • 10.5.4.2. Financial Performance
    • 10.5.4.3. Product Benchmarking
    • 10.5.4.4. Recent Developments/ Strategic Initiatives
  • 10.5.5. GALDERMA
    • 10.5.5.1. Participant's Overview
    • 10.5.5.2. Financial Performance
    • 10.5.5.3. Product Benchmarking
    • 10.5.5.4. Recent Developments/ Strategic Initiatives
  • 10.5.6. Amgen Inc.
    • 10.5.6.1. Participant's Overview
    • 10.5.6.2. Financial Performance
    • 10.5.6.3. Product Benchmarking
    • 10.5.6.4. Recent Developments/ Strategic Initiatives
  • 10.5.7. Johnson & Johnson Services, Inc.
    • 10.5.7.1. Participant's Overview
    • 10.5.7.2. Financial Performance
    • 10.5.7.3. Product Benchmarking
    • 10.5.7.4. Recent Developments/ Strategic Initiatives
  • 10.5.8. Novartis AG
    • 10.5.8.1. Participant's Overview
    • 10.5.8.2. Financial Performance
    • 10.5.8.3. Product Benchmarking
    • 10.5.8.4. Recent Developments/ Strategic Initiatives
  • 10.5.9. Eli Lilly and Company
    • 10.5.9.1. Participant's Overview
    • 10.5.9.2. Financial Performance
    • 10.5.9.3. Product Benchmarking
    • 10.5.9.4. Recent Developments/ Strategic Initiatives
  • 10.5.10. Almirall, S.A
    • 10.5.10.1. Participant's Overview
    • 10.5.10.2. Financial Performance
    • 10.5.10.3. Product Benchmarking
    • 10.5.10.4. Recent Developments/ Strategic Initiatives
  • 10.5.11. Bausch Health Companies Inc.
    • 10.5.11.1. Participant's Overview
    • 10.5.11.2. Financial Performance
    • 10.5.11.3. Product Benchmarking
    • 10.5.11.4. Recent Developments/ Strategic Initiatives